Hao Cai Selected Research

POEMS Syndrome (Syndrome, POEMS)

11/2021	Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome.
6/2021	Cereblon expression is a prognostic marker in newly diagnosed POEMS syndrome treated with lenalidomide plus dexamethasone.
3/2019	Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
1/2019	What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?
8/2018	Impact of lenalidomide exposure on blood cell collection for autotransplants in persons with POEMS syndrome.
1/2018	A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.
1/2018	Prognostic value of serum vascular endothelial growth factor and hematological responses in patients with newly-diagnosed POEMS syndrome.
9/2017	OCULAR MANIFESTATIONS AND TREATMENT OUTCOMES IN CHINESE PATIENTS WITH POEMS SYNDROME.
11/2016	Remarkable expression of vascular endothelial growth factor in bone marrow plasma cells of patients with POEMS syndrome.
2/2016	Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: incidence, treatment and outcome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hao Cai Research Topics

Disease

60	Neoplasms (Cancer) 01/2023 - 06/2005
21	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2013
14	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2015
13	POEMS Syndrome (Syndrome, POEMS) 11/2021 - 06/2014
9	Neoplasm Metastasis (Metastasis) 10/2021 - 03/2014
7	Inflammation (Inflammations) 01/2022 - 01/2013
5	Stomach Neoplasms (Stomach Cancer) 02/2016 - 08/2009
4	Infections 01/2022 - 09/2012
4	Insulin Resistance 01/2022 - 01/2018
4	Liver Neoplasms (Liver Cancer) 01/2021 - 01/2017
4	Carcinogenesis 01/2021 - 01/2014
4	Diarrhea 03/2019 - 05/2013
4	Pancreatitis 07/2014 - 10/2013
3	Multiple Myeloma 01/2022 - 06/2017
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 12/2015
3	Paraproteinemias (Monoclonal Gammopathy) 01/2018 - 11/2016
3	Necrosis 01/2017 - 01/2014
2	Reperfusion Injury 01/2022 - 01/2022
2	Infarction (Infarctions) 01/2022 - 01/2019
2	Myocardial Infarction 01/2022 - 01/2019
2	Erdheim-Chester Disease 01/2022 - 10/2019
2	Ischemia 01/2022 - 01/2022
2	Obesity 01/2022 - 08/2015
2	Fibrosis (Cirrhosis) 12/2021 - 01/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2017
2	Glioma (Gliomas) 01/2021 - 01/2021
2	Anaphylaxis (Anaphylactic Shock) 12/2020 - 01/2020
2	Pain (Aches) 10/2020 - 01/2012
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 08/2020 - 06/2017
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2020 - 06/2017
2	Rhinitis 04/2019 - 02/2018
2	Allergic Rhinitis 04/2019 - 12/2018
2	Ulcerative Colitis 03/2019 - 03/2017
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 03/2019 - 04/2018
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 03/2019 - 06/2018
2	Cicatrix (Scar) 01/2019 - 06/2009

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 05/2022 - 07/2015
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2009
8	Messenger RNA (mRNA)IBA 06/2021 - 06/2009
7	ProdrugsIBA 02/2022 - 03/2017
7	Biological ProductsIBA 01/2021 - 11/2010
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2019 - 12/2014
6	EnzymesIBA 01/2022 - 05/2015
6	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 10/2015
5	Phosphotransferases (Kinase)IBA 01/2022 - 08/2015
5	Therapeutic UsesIBA 01/2022 - 01/2017
5	Lenalidomide (CC 5013)FDA Link 06/2021 - 10/2015
5	Biomarkers (Surrogate Marker)IBA 06/2021 - 10/2015
5	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2015
5	BaizhuIBA 03/2019 - 05/2013
5	oridoninIBA 01/2016 - 06/2012
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2017
4	PolymersIBA 01/2022 - 11/2017
4	Estrogen ReceptorsIBA 01/2020 - 01/2016
4	Emodin (Archin)IBA 02/2019 - 10/2013
4	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 03/2015
3	Contrast MediaIBA 01/2023 - 04/2017
3	CytokinesIBA 01/2022 - 01/2017
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 08/2019
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2021 - 04/2017
3	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 04/2015
3	RNA (Ribonucleic Acid)IBA 01/2020 - 11/2017
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 01/2013
3	cang er zi wanIBA 04/2019 - 02/2018
3	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 12/2015
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 09/2013
2	phytochlorinIBA 02/2022 - 01/2022
2	Photosensitizing Agents (Photosensitizers)IBA 02/2022 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 10/2021
2	LigandsIBA 01/2022 - 01/2021
2	Cell-Free Nucleic AcidsIBA 01/2022 - 08/2020
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 12/2020
2	AntigensIBA 01/2022 - 01/2021
2	AntibodiesIBA 01/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 11/2020
2	Oxygen (Dioxygen)IBA 01/2022 - 07/2015
2	Collagen Type I (Type I Collagen)IBA 07/2021 - 06/2014
2	GadoliniumIBA 02/2021 - 04/2017
2	Janus Kinase 2IBA 01/2021 - 12/2013
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 10/2015
2	Immunoglobulin M (IgM)IBA 01/2019 - 06/2017
2	Melphalan (Alkeran)FDA LinkGeneric 01/2019 - 10/2015
2	Peptides (Polypeptides)IBA 01/2019 - 04/2017
2	CationsIBA 01/2019 - 05/2016
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 05/2016
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 05/2016
2	CollagenIBA 01/2019 - 07/2014
2	IntegrinsIBA 12/2018 - 10/2018
2	CreatinineIBA 08/2018 - 07/2014
2	Cystatin CIBA 08/2018 - 01/2018

Therapy/Procedure

35	Therapeutics 02/2022 - 06/2005
10	Drug Therapy (Chemotherapy) 01/2022 - 10/2015
7	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2018 - 01/2013
3	Hepatectomy 12/2022 - 01/2019
2	Aftercare (After-Treatment) 09/2022 - 04/2015
2	Liver Transplantation 06/2022 - 01/2022
2	Immunotherapy 01/2022 - 01/2021
2	Neoadjuvant Therapy 01/2021 - 01/2020
2	Transplantation 08/2020 - 01/2019
2	Stem Cell Transplantation 01/2019 - 10/2015